97 related articles for article (PubMed ID: 11224496)
21. Molecular cytogenetic findings in a three-way novel variant of t(1;8;21)(p35;q22;q22): a unique relocation of the AML1/ETO fusion gene 1p35 in AML-M2.
Ahmad F; Kokate P; Chheda P; Dalvi R; Das BR; Mandava S
Cancer Genet Cytogenet; 2008 Jan; 180(2):153-7. PubMed ID: 18206543
[TBL] [Abstract][Full Text] [Related]
22. Identification of truncated RUNX1 and RUNX1-PRDM16 fusion transcripts in a case of t(1;21)(p36;q22)-positive therapy-related AML.
Stevens-Kroef MJ; Schoenmakers EF; van Kraaij M; Huys E; Vermeulen S; van der Reijden B; van Kessel AG
Leukemia; 2006 Jun; 20(6):1187-9. PubMed ID: 16598304
[No Abstract] [Full Text] [Related]
23. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
[TBL] [Abstract][Full Text] [Related]
24. AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.
Wang YY; Zhou GB; Yin T; Chen B; Shi JY; Liang WX; Jin XL; You JH; Yang G; Shen ZX; Chen J; Xiong SM; Chen GQ; Xu F; Liu YW; Chen Z; Chen SJ
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1104-9. PubMed ID: 15650049
[TBL] [Abstract][Full Text] [Related]
25. RUNX1-MTG16 fusion gene in de novo acute myeloblastic leukemia with t(16;21)(q24;q22).
Athanasiadou A; Stalika E; Sidi V; Papaioannou M; Gaitatzi M; Anagnostopoulos A
Leuk Lymphoma; 2011 Jan; 52(1):145-7. PubMed ID: 21054152
[No Abstract] [Full Text] [Related]
26. The 8;21 translocation in leukemogenesis.
Peterson LF; Zhang DE
Oncogene; 2004 May; 23(24):4255-62. PubMed ID: 15156181
[TBL] [Abstract][Full Text] [Related]
27. Identification of novel Runx1 (AML1) translocation partner genes SH3D19, YTHDf2, and ZNF687 in acute myeloid leukemia.
Nguyen TT; Ma LN; Slovak ML; Bangs CD; Cherry AM; Arber DA
Genes Chromosomes Cancer; 2006 Oct; 45(10):918-32. PubMed ID: 16858696
[TBL] [Abstract][Full Text] [Related]
28. The transcriptional corepressor MTG16a contains a novel nucleolar targeting sequence deranged in t (16; 21)-positive myeloid malignancies.
Hoogeveen AT; Rossetti S; Stoyanova V; Schonkeren J; Fenaroli A; Schiaffonati L; van Unen L; Sacchi N
Oncogene; 2002 Sep; 21(43):6703-12. PubMed ID: 12242670
[TBL] [Abstract][Full Text] [Related]
29. Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib.
Schafhausen P; Dierlamm J; Bokemeyer C; Bruemmendorf TH; Bacher U; Zander AR; Schnittger S; Hochhaus A
Cancer Genet Cytogenet; 2009 Feb; 189(1):63-7. PubMed ID: 19167615
[No Abstract] [Full Text] [Related]
30. Aleukaemic acute myeloid leukaemia with t(8;21)(q22;q22).
Wong KF; Siu LL; Wong WS
Br J Haematol; 2009 Aug; 146(4):345. PubMed ID: 19222479
[No Abstract] [Full Text] [Related]
31. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.
Yan M; Kanbe E; Peterson LF; Boyapati A; Miao Y; Wang Y; Chen IM; Chen Z; Rowley JD; Willman CL; Zhang DE
Nat Med; 2006 Aug; 12(8):945-9. PubMed ID: 16892037
[TBL] [Abstract][Full Text] [Related]
32. Novel RUNX1-PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22).
Sakai I; Tamura T; Narumi H; Uchida N; Yakushijin Y; Hato T; Fujita S; Yasukawa M
Genes Chromosomes Cancer; 2005 Nov; 44(3):265-70. PubMed ID: 16015645
[TBL] [Abstract][Full Text] [Related]
33. Chromosomal translocations in secondary acute myeloid leukemia.
Rowley JD; Vignon C; Gollin SM; Rosenberg CL; Wyandt HE; Milunsky A
N Engl J Med; 1996 Feb; 334(9):601-3. PubMed ID: 8569841
[No Abstract] [Full Text] [Related]
34. Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias.
Krauter J; Gorlich K; Ottmann O; Lubbert M; Dohner H; Heit W; Kanz L; Ganser A; Heil G
J Clin Oncol; 2003 Dec; 21(23):4413-22. PubMed ID: 14645432
[TBL] [Abstract][Full Text] [Related]
35. Complex chromosome 8;21 translocation with associated hyperdiploidy in acute myeloid leukemia (FAB-M2).
Corral Mdel P; Villa O; Alfaro EM; Alonso CN; Baro C; Felice MS; Rossi J; Solé F; Gallego MS
Pediatr Blood Cancer; 2008 Mar; 50(3):651-4. PubMed ID: 17405156
[TBL] [Abstract][Full Text] [Related]
36. Translocation (8;21)(q22;q22) without rearrangement of RUNX1 and RUNX1T1 genes in a patient with refractory anemia with excess of blasts.
Aguilar A; Talavera M; Villalon C; Garcia-Sagredo JM; de Leon A; Sordo T; Cabello P; Gonzalez FA; Garcia-Galloway E; San Roman C; Ferro T
Cancer Genet Cytogenet; 2008 Jan; 180(1):85-6. PubMed ID: 18068542
[No Abstract] [Full Text] [Related]
37. Acute myeloid leukemia associated with variant t(8;21) detected by conventional cytogenetic and molecular studies: a report of four cases and review of the literature.
Huang L; Abruzzo LV; Valbuena JR; Medeiros LJ; Lin P
Am J Clin Pathol; 2006 Feb; 125(2):267-72. PubMed ID: 16393685
[TBL] [Abstract][Full Text] [Related]
38. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.
Pabst T; Mueller BU; Harakawa N; Schoch C; Haferlach T; Behre G; Hiddemann W; Zhang DE; Tenen DG
Nat Med; 2001 Apr; 7(4):444-51. PubMed ID: 11283671
[TBL] [Abstract][Full Text] [Related]
39. [The role of TEL and AML1 genes in the pathogenesis of hematologic malignancies].
Zuna J
Cas Lek Cesk; 2001 Mar; 140(5):131-7. PubMed ID: 11347199
[TBL] [Abstract][Full Text] [Related]
40. Therapy-related acute myeloid leukemia with inv(16) after successful therapy for de novo acute myeloid leukemia with t(8;21).
Shao H; Yang Q; Wu C; Cen J; Chen S; Pan J
Ann Hematol; 2017 Dec; 96(12):2127-2129. PubMed ID: 28840298
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
